Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src [Oncotarget, 7, 22, (33111-33124) (2016)] DOI: 10.18632/oncotarget.8880

  1. Perez, M.
  2. Lucena-Cacace, A.
  3. Marín-Gómez, L.M.
  4. Padillo-Ruiz, J.
  5. Robles-Frias, M.J.
  6. Saez, C.
  7. Garcia-Carbonero, R.
  8. Carnero, A.
Aldizkaria:
Oncotarget

ISSN: 1949-2553

Argitalpen urtea: 2016

Alea: 7

Zenbakia: 47

Orrialdeak: 78219-78219

Mota: Hutsen zuzenketa

DOI: 10.18632/ONCOTARGET.13482 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus